TUBOCURARINE CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tubocurarine Chloride, and what generic alternatives are available?
Tubocurarine Chloride is a drug marketed by Bristol Myers Squibb, Hospira, and Lilly. and is included in three NDAs.
The generic ingredient in TUBOCURARINE CHLORIDE is tubocurarine chloride. There are four drug master file entries for this compound. Additional details are available on the tubocurarine chloride profile page.
Summary for TUBOCURARINE CHLORIDE
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Patent Applications: | 2,670 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TUBOCURARINE CHLORIDE at DailyMed |
Medical Subject Heading (MeSH) Categories for TUBOCURARINE CHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TUBOCURARINE CHLORIDE
US Patents and Regulatory Information for TUBOCURARINE CHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | TUBOCURARINE CHLORIDE | tubocurarine chloride | INJECTABLE;INJECTION | 005657-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | TUBOCURARINE CHLORIDE | tubocurarine chloride | INJECTABLE;INJECTION | 006095-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | TUBOCURARINE CHLORIDE | tubocurarine chloride | INJECTABLE;INJECTION | 006325-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |